title: Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampisa associated with fetal growth restriction?
authors.affiliation: a Department of Woman, Mother and Neonate , Biomedical and Clinical School of Medicine, University of Milan Medical School , via Castelvetro 32 , Milan 20154 Italy .
authors.forename: Enrico
authors.initials: E
authors.lastname: Ferrazzi
authors.forename: Marialuisa
authors.initials: M
authors.lastname: Muggiasca
authors.forename: Maria-Teresa
authors.initials: MT
authors.lastname: Gervasi
mesh_terms: D005260:Female; D005317:Fetal Growth Retardation / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D015201:Meta-Analysis as Topic; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000453:epidemiology; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology
chemical_list: D006495:Heparin, Low-Molecular-Weight